The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Original Article
PreviousPrevious
Volume 338:640-644 March 5, 1998 Number 10
NextNext

Variations in the NRAMP1 Gene and Susceptibility to Tuberculosis in West Africans
Richard Bellamy, M.R.C.P., Cyril Ruwende, D.Phil., Tumani Corrah, Ph.D., Keith P.W.J. McAdam, F.R.C.P., Hilton C. Whittle, F.R.C.P., and Adrian V.S. Hill, D.Phil., D.M.

 

This Article
-Abstract
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
ABSTRACT

Background Genetic factors may affect the susceptibility to tuberculosis, but no specific genes governing susceptibility have been identified. In mice, natural resistance to infection with some mycobacteria is influenced by the gene for natural-resistance–associated macrophage protein 1 (Nramp1 ), but the role of the human homologue of this gene, NRAMP1, in tuberculosis is unknown. We typed polymorphisms in NRAMP1 in a case–control study of tuberculosis in the Gambia, West Africa.

Methods Sequence-specific oligonucleotide hybridization and microsatellite analysis were used to type NRAMP1 polymorphisms in 410 adults (mean age, 34.7 years) with smear-positive pulmonary tuberculosis and 417 ethnically matched, healthy controls. Patients with human immunodeficiency virus infection were excluded.

Results Four NRAMP1 polymorphisms were each significantly associated with tuberculosis. Subjects who were heterozygous for two NRAMP1 polymorphisms in intron 4 and the 3' untranslated region of the gene were particularly overrepresented among those with tuberculosis, as compared with those with the most common NRAMP1 genotype (odds ratio, 4.07; 95 percent confidence interval, 1.86 to 9.12; chi-square = 14.58; P<0.001).

Conclusions Genetic variation in NRAMP1 affects susceptibility to tuberculosis in West Africans.

Among inbred strains of mice, natural resistance to infection with several intracellular pathogens is controlled by a single dominant gene, designated Bcg (also known as Lsh/Ity).1,2,3 Two distinct phenotypes, Bcg s and Bcg r, are associated with susceptibility and resistance, respectively, to the early stage of infection with Mycobacterium bovis (bacille Calmette–Guérin),3 M. avium complex,4 M. lepraemurium,5 Leishmania donovani,2,6 and Salmonella typhimurium.1 A candidate gene was isolated by positional cloning and designated the natural-resistance–associated macrophage protein 1 gene (Nramp1 ).7 Nramp1 is expressed only in reticuloendothelial cells.7 A single nonconservative amino acid substitution of aspartic acid for glycine at position 169 is correlated with the susceptibility phenotype (Bcg s) in 27 inbred mouse strains.7,8 That Nramp1 and Bcg are identical has been proved by the production of an Nramp1 knockout mouse that is phenotypically identical to the homozygous Nramp1D169 mouse9 and by the restoration of the resistance phenotype in transgenic mice in which the Nramp1G169 allele was transferred onto the background of the Nramp1D169 genotype.10 These findings conclusively demonstrated that Nramp1 has an important role in determining resistance to mycobacteria and other intracellular pathogens in mice.

In the majority of humans, an effective immune response develops after infection with M. tuberculosis and restricts the spread of the pathogen. Less than 10 percent of infected persons ever have clinical disease, and only a minority of such persons have an identifiable risk factor, such as diabetes, advanced age, alcohol abuse, human immunodeficiency virus (HIV) infection, or use of corticosteroids. In the remainder, a complex interaction of genetic and environmental factors probably causes the development of disease. Racial variation in the susceptibility to tuberculosis11,12 and studies in twins13,14 strongly suggest that genetic factors are important in the susceptibility to tuberculosis.

The human homologue of the Nramp1 gene, designated NRAMP1, is a strong candidate gene for human tuberculosis. NRAMP1 has been cloned and mapped to human chromosome 2q35.15,16 Several polymorphisms have been described in the NRAMP1 gene, and it has been suggested that they may influence the gene's function.16,17,18,19 To determine whether NRAMP1 polymorphisms are associated with susceptibility to tuberculosis, we performed a case–control study comparing the frequency of several polymorphisms in the NRAMP1 gene in West Africans with tuberculosis and ethnically matched healthy controls.

Methods

Patients and Controls

Patients over 16 years old with smear-positive pulmonary tuberculosis were identified at three tuberculosis–leprosy clinics in the western region of the Gambia, in and around the capital, Banjul. Patients were included only after examination of sputum specimens by experienced microscopists had confirmed the presence of acid-fast bacilli. In the Gambia, the majority of persons in whom tuberculosis is diagnosed are adults who present with advanced, smear-positive pulmonary disease. The patients in this study had more severe disease than that generally seen in developed countries. A total of 410 patients (more than 90 percent of those who were eligible) provided oral informed consent. Their mean (±SD) age was 34.7±13.2 years, and 67.4 percent were male.

Sequential unrelated blood donors from the Royal Victoria Hospital, Banjul, were recruited as controls. The transfusion center serves the geographic area from which the patients were recruited. A total of 417 blood donors (95 percent of those recruited) agreed to participate. All were male, and their mean age was 30.3±7.5 years. The controls were retrospectively matched with the patients according to ethnic group, as far as the numbers allowed. The study was approved by the joint ethics committee of the Gambian government and the Medical Research Council.

The following ethnic groups were represented: Mandinka (accounting for 38.5 percent of the patients with tuberculosis and 37.4 percent of the controls), Wolof (19.1 and 18.4 percent), Jola (17.9 and 16.9 percent), Fula (12.0 and 12.2 percent), Manjago (2.5 and 3.3 percent), Serrahule (2.7 and 3.8 percent), and other, less common groups such as Aku and Serere (7.3 and 8.0 percent). These ethnic groups have previously been shown to be closely related genetically.20 Persons known to have come from regions outside the Gambia were not included.

Patients known to be infected with HIV were not recruited, and 95 percent of the patients who agreed to participate were screened for HIV antibodies. HIV-positive patients were excluded. All controls were HIV-negative. The combined prevalence of HIV types 1 and 2 in the Gambia is relatively low, around 1.5 percent in the general population and less than 10 percent among patients with tuberculosis (unpublished data).

NRAMP1 Genotyping

The NRAMP1 polymorphisms typed were a (CA)n microsatellite in the immediate 5' region of the gene,17 denoted here 5'(CA)n; a single nucleotide change in intron 4 (469+14G/C),18 denoted here INT4; a nonconservative single-base substitution at codon 543 that changes aspartic acid to asparagine (D543N)18; and a TGTG deletion in the 3' untranslated region (1729+55del4),18 denoted here 3'UTR. DNA was extracted from whole venous blood with the use of Nucleon II kits (Scotlab).

A region of approximately 200 bp surrounding the (CA)n microsatellite was amplified by means of the polymerase chain reaction (PCR) with the use of the primers 5'ACTCGCATTAGGCCAACGAG3' and fluorescein-labeled 5'TTCTGTGCCTCCCA-AGTTAGC3' (developed by John Todd and coworkers, Oxford, United Kingdom). PCR products were genotyped by electrophoresis on 6 percent polyacrylamide gels, with the use of an ABI 373 sequencer and the computer software Genescan and Genotyper (Perkin–Elmer).21 The PCR primers for the INT4 polymorphism were 5'CTCTGGCTGAAGGCTCTCC3' and 5'TGTGCTATCAGTTGAGCCTC3'; the primers for D543N and 3'UTR were 5'GCATCTCCCCAATTCATGGT3' and 5'AACTGTCCCACTCTATCCTG3'.18 The single-base substitutions and 4-bp deletion were detected by slot blotting PCR product to a nylon membrane, hybridization with digoxigenin-labeled sequence-specific oligonucleotides, and signal detection with an antidigoxigenin-antibody chemiluminescence system (Boehringer Mannheim). The sequence-specific oligonucleotides used were 5'TTGGGGGGCCTGGAC3' and 5'TTGGGGGCCCTGGAC3' for INT4 variants, 5'TTGAAGAGAACCAGAA3' and 5'TTGAAGAGGACCAGAA3' for D543N, and 5'CTGGATGTGGAGGGG3' and 5'TGCTGGAGAGGGGGC3' for 3'UTR.15

Statistical Analysis

Statistical analysis was performed in a stepwise manner. Overall genotype frequencies were compared initially with the use of a three-by-two chi-square test with 2 df. If there was a significant overall difference between cases and controls (P<0.05), individual genotypes were compared with the use of a two-by-two chi-square test with 1 df. To allow for any potential confounding effect of ethnic group, chi-square analysis was also performed with the use of the Mantel–Haenszel test and stratification according to ethnic group. The influence of linked variation on genotypic associations was assessed by logistic regression.

Results

The NRAMP1 allelic frequencies for the INT4, D543N, and 3'UTR variants differed significantly among the ethnic groups (Table 1). This finding highlights the importance of recording accurate data on ethnic origin when carrying out genetic case–control studies. The Gambian population is well suited to genetic studies because persons can be classified precisely with respect to membership in relatively closely related ethnic groups, which is rarely possible with Western populations. Mantel–Haenszel chi-square tests were performed after stratification according to ethnic group in order to correct for this potential confounding factor (Table 2).

View this table:
[in this window]
[in a new window]
  		Table 1. NRAMP1 Allelic Frequencies among 827 Gambians, According to Ethnic Group.

 
View this table:
[in this window]
[in a new window]
  		Table 2. Relation between NRAMP1 Polymorphisms and Tuberculosis in the Gambia.

 
The four polymorphisms, 5'(CA)n, INT4, D543N, and 3'UTR, were each significantly associated with tuberculosis (P = 0.03, P =0.009, P =0.008, and P< 0.001, respectively). The 5'(CA)n microsatellite and INT4 variant were in significant linkage disequilibrium, with the 5'(CA)n 201-bp allele strongly associated with the INT4 C allele (P<0.001), and these results are therefore not independent. In addition, the D543N A allele was always associated with the 3'UTR del allele (P<0.001), and these results are therefore also not independent of each other. The 3'UTR del/D543N G haplotype was found in this population, whereas it is absent in Europeans and Asians18 (and unpublished data). The INT4 and 3'UTR alleles were not significantly associated with each other (chi-square = 0.83, P = 0.93), and both were independently and significantly associated with tuberculosis (on logistic-regression analysis, P = 0.006 for INT4 and P = 0.004 for 3'UTR; after stratification for the presence or absence of INT4, Mantel–Haenszel chi-square = 7.73 with 1 df for 3'UTR, P = 0.005; and after stratification for the presence or absence of 3'UTR, Mantel–Haenszel chi-square = 7.708 with 1 df for INT4, P = 0.006). There were small differences in the total number of persons in whom typing was performed for each polymorphism, since very limited quantities of DNA were available from a few persons.

Two additional polymorphisms in the NRAMP1 gene were typed: a C-to-T single-base transition at a position 236 bp before the transcription starting site19 and a 9-bp coding deletion within exon 2.17 The 9-bp deletion was very uncommon (allelic frequency, <1 percent), and the -236C/T polymorphism was not associated with tuberculosis (chi-square = 2.82, P = 0.25; data not shown).

Combined analysis of the INT4 and 3'UTR polymorphisms showed a strong association with tuberculosis (chi-square =26.41 with 3 df, P<0.001) (Table 3). As compared with GG/++ homozygotes, heterozygotes for the INT4 C allele or the 3'UTR del allele were overrepresented among the patients with tuberculosis (odds ratio for INT4 C, 1.79; 95 percent confidence interval, 1.07 to 3.00; odds ratio for 3'UTR, 1.85; 95 percent confidence interval, 1.30 to 2.62). This finding was consistent among all the ethnic groups studied (six of the seven ethnic groups had high numbers of INT4 heterozygotes and all seven had high numbers of 3'UTR heterozygotes among the patients with tuberculosis). Heterozygosity for both these variants was associated with the highest risk of tuberculosis (odds ratio, 4.07; 95 percent confidence interval, 1.86 to 9.12).

View this table:
[in this window]
[in a new window]
  		Table 3. Combined Analysis of NRAMP1 INT4 and 39UTR Variants.

 
Discussion

A mutation in Nramp1 results in susceptibility to several mycobacterial species among inbred mouse strains.7,8,9,10 Our study showed that variation in the human homologue NRAMP1 is associated with altered susceptibility to smear-positive tuberculosis. It is likely that the NRAMP1 gene governs susceptibility to tuberculosis. Although it is possible that the association described here is due to linkage disequilibrium between variation in NRAMP1 and another nearby susceptibility gene, this explanation is unlikely, because NRAMP1 is a strong candidate gene for tuberculosis on the basis of studies of its murine homologue.

The study design we used does not distinguish between susceptibility to infection with M. tuberculosis and susceptibility to disease progression. However, most healthy Gambians in the age range we studied have been infected with M. tuberculosis. Since only approximately 1 in 10 persons infected with M. tuberculosis will ever have clinical disease,22 patients with tuberculosis have greater susceptibility to this pathogen than the general population. Human NRAMP1 is therefore probably important in the development of overt disease, in contrast to murine Nramp1, which determines the ability to control bacille Calmette–Guérin in the early stages of infection. There may be differences between species in the functional consequences of Nramp1 variation, because human and murine macrophages exhibit marked differences in their ability to inhibit the growth of virulent mycobacteria and in the mechanisms they use.23 It is unclear whether the INT4 and 3'UTR variants affect NRAMP1 function or whether they are in linkage disequilibrium with another functional polymorphism that has not yet been described. However, allelic variation in the 5'(CA)n repeat may be of functional importance.24

The 3'UTR variant allele associated with susceptibility to tuberculosis is very uncommon in Europeans18 but was present in about a quarter of this West African population. These findings may in part explain why American blacks have greater susceptibility to tuberculosis than whites.11,12 NRAMP1 polymorphism will need to be assessed in large case–control studies of whites and Asians to determine whether the gene also governs susceptibility to tuberculosis in other racial groups.

The functions of Nramp1 in mice and NRAMP1 in humans remain unknown. Mice homozygous for the Nramp1 susceptibility allele have increased susceptibility to several antigenically unrelated intracellular pathogens in vivo, and macrophages from such mice have an impaired capacity to restrict the growth of mycobacteria,2,25,26 salmonella,27 and leishmania28 in vitro. Thus, studies of the NRAMP1 susceptibility genotype identified here will be of interest in determining susceptibility to leprosy, typhoid fever, and leishmaniasis. Nramp1 protein is localized to the late endocytic compartment of resting macrophages and, after phagocytosis, is recruited to the membrane of the phagosome.29 These findings suggest that Nramp1 may restrict the replication of intracellular pathogens by altering the phagolysosomal environment.30 The related but unlinked gene Nramp2 has been shown to encode an iron transporter.31,32 The yeast Nramp1 homologue SMF1 is important for the regulation of manganese-ion uptake, and it has been suggested that Nramp1 may therefore function as a regulator of intraphagosomal manganese,30 iron, or other divalent cations.29

In the Gambia, heterozygotes for the INT4 and 3'UTR variants are at increased risk for tuberculosis, whereas among mice, only homozygotes for the Nramp1 D169 variant are susceptible to intracellular pathogens. The small number of homozygotes in our study precludes a definitive analysis of their susceptibility to tuberculosis, but they do not appear to be more susceptible than heterozygotes. These findings suggest that with the human NRAMP1 variants, the tuberculosis-susceptibility allele is dominant, whereas with the murine Nramp1D169 variant, the resistance allele is dominant. However, it is possible that incomplete linkage disequilibrium between the typed polymorphisms and an unknown mutation affecting function has obscured the true dominance pattern of the resistance and susceptibility genotypes. Alternatively, the heterozygous genotype of NRAMP1 may lead to a divalent cation concentration in the human phagolysosome, which is more conducive to mycobacterial growth than either of the homozygous genotypes. Finally, it is also possible that NRAMP1-variant homozygotes who are infected with M. tuberculosis in childhood succumb to the disease rapidly and are therefore not overrepresented among adults with tuberculosis.

The association of NRAMP1 variation with a major infectious disease provides support for the strategy of mapping and identifying genes for resistance to infectious disease in mice and then testing their homologues as candidate genes for susceptibility to related infections in humans. Further analysis of the mechanism of action of NRAMP1 and its genetic variants may lead to new approaches to controlling tuberculosis, which kills more people than any other disease caused by an infectious pathogen.33

Supported by a grant from the Wellcome Trust (044418/Z/95/Z/139). Dr. Bellamy is a Wellcome Trust Training Fellow in Tropical Medicine, and Dr. Hill is a Wellcome Trust Principal Research Fellow.

We are indebted to all the subjects who agreed to participate in this study; to Gambian National Tuberculosis Control Programme Directors Drs. V. Bouchier and K. Manneh and their staff, especially M. Saidykhan, K. Bayang, E. Mendy, M. Jallow, M. Sanyang, and S. Gassama, for their assistance; and to field workers Y. Sowe and M. Jawo and other Medical Research Council staff, especially S. Sabally, S. Obarro, K. Joof, E. Harding, V. Thomas, P. Langfield, and P. Njie, for their assistance.


Source Information

From the Wellcome Trust Centre for Human Genetics, Oxford University, Oxford, United Kingdom (R.B., C.R., A.V.S.H.), and the Medical Research Council Laboratories, Fajara, the Gambia (T.C., K.P.W.J.M., H.C.W.).

Address reprint requests to Professor Hill at the Wellcome Trust Centre for Human Genetics, Windmill Rd., Oxford OX3 7BN, United Kingdom.

References

  1. Plant JE, Glynn A. Genetics of resistance to infection with Salmonella typhimurium in mice. J Infect Dis 1976;133:72-78. [Medline]
  2. Bradley DJ. Regulation of Leishmania populations within the host. II. Genetic control of acute susceptibility of mice to Leishmania donovani infection. Clin Exp Immunol 1977;30:130-140. [Medline]
  3. Gros P, Skamene E, Forget A. Genetic control of natural resistance to Mycobacterium bovis BCG in mice. J Immunol 1981;127:417-421. [Abstract]
  4. Goto Y, Buschman E, Skamene E. Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics 1989;30:218-221. [CrossRef][Medline]
  5. Skamene E, Gros P, Forget A, Patel PJ, Nesbitt MN. Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics 1984;19:117-124. [CrossRef][Medline]
  6. Skamene E, Gros P, Forget A, Kongshavn PAL, St Charles C, Taylor BA. Genetic regulation of resistance to intracellular pathogens. Nature 1982;297:506-509. [CrossRef][Medline]
  7. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell 1993;73:469-485. [CrossRef][Medline]
  8. Malo D, Vogan K, Vidal S, et al. Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 1994;23:51-61. [CrossRef][Medline]
  9. Vidal S, Tremblay ML, Govoni G, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995;182:655-666. [Free Full Text]
  10. Govoni G, Vidal S, Gauthier S, Skamene E, Malo D, Gros P. The Bcg/Ity/Lsh locus: genetic transfer of resistance to infections in C57BL/6J mice transgenic for the Nramp1Gly169 allele. Infect Immun 1996;64:2923-2929. [Abstract]
  11. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990;322:422-427. [Abstract]
  12. Stead WW. Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann Intern Med 1992;116:937-941.
  13. Kallmann FJ, Reisner D. Twin studies on the significance of genetic factors in tuberculosis. Am Rev Tuberc 1942;47:549-74.
  14. Comstock GW. Tuberculosis in twins: a re-analysis of the Prophit survey. Am Rev Respir Dis 1978;117:621-624. [Medline]
  15. Cellier M, Govoni G, Vidal S, et al. Human natural resistance-associated macrophage protein: cDNA cloning, chromosomal mapping, genomic organization, and tissue-specific expression. J Exp Med 1994;180:1741-1752. [Free Full Text]
  16. Blackwell JM, Barton CH, White JK, et al. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995;1:194-205. [Medline]
  17. White JK, Shaw M-A, Barton CH, et al. Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification ofa polymorphic repeat in exon 2 of NRAMP. Genomics 1994;24:295-302. [CrossRef][Medline]
  18. Liu J, Fujiwara TM, Buu NT, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995;56:845-853. [Medline]
  19. Lewis L-A, Victor TC, Helden EGH, et al. Identification of C to T mutation at position -236 bp in the human NRAMP1 gene promoter. Immunogenetics 1996;44:309-311. [Medline]
  20. Allsopp CEM, Harding RM, Taylor C, et al. Interethnic genetic differentiation in Africa: HLA class I antigens in the Gambia. Am J Hum Genet 1992;50:411-421. [Medline]
  21. Ziegle JS, Su Y, Corcoran KP, et al. Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics 1992;14:1026-1031. [CrossRef][Medline]
  22. Rook GAW. Role of activated macrophages in the immunopathology of tuberculosis. Br Med Bull 1988;44:611-623. [Free Full Text]
  23. Murray CJL, Styblo K, Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990;65:6-24. [Medline]
  24. Blackwell JM. Structure and function of the natural-resistance-associated macrophage protein (Nramp1), a candidate protein for infectious and autoimmune disease susceptibility. Mol Med Today 1996;2:205-211. [CrossRef][Medline]
  25. Stach JL, Gros P, Forget A, Skamene E. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol 1984;132:888-892. [Abstract]
  26. Denis M, Forget A, Pelletier M, Gervais F, Skamene E. Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice. J Leukoc Biol 1990;47:25-30. [Abstract]
  27. Lissner CR, Swanson RN, O'Brien AD. Genetic control of the innate resistance of mice to Salmonella typhimurium: expression of the Ity gene in peritoneal and splenic macrophages isolated in vitro. J Immunol 1983;131:3006-3013. [Abstract]
  28. Crocker PR, Blackwell JM, Bradley DJ. Expression of the natural resistance gene Lsh in resident liver macrophages. Infect Immun 1984;43:1033-1040. [Free Full Text]
  29. Gruenheid S, Pinner E, Desjardins M, Gros P. Natural resistance to infection with intracellular pathogens: the Nramp 1 protein is recruited to the membrane of the phagosome. J Exp Med 1997;185:717-730. [Free Full Text]
  30. Supek F, Supekova L, Nelson H, Nelson N. A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. Proc Natl Acad Sci U S A 1996;93:5105-5110. [Free Full Text]
  31. Gunshin H, Mackenzie B, Berger UV, et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997;388:482-488. [CrossRef][Medline]
  32. Fleming MD, Trenor CC III, Su MA, et al. Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat Genet 1997;16:383-386. [CrossRef][Medline]
  33. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349:1269-1276. [CrossRef][Medline]

 

This Article
-Abstract
- PDF

Commentary
-Letters

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation

Related Letters:

The NRAMP1 Gene and Susceptibility to Tuberculosis
Borgdorff M. W., Miles T. P., McBride D., Bellamy R., Hill A. V.S., Bloom B. R., Small P. M.
Extract | Full Text  
N Engl J Med 1998; 339:199-201, Jul 16, 1998. Correspondence

This article has been cited by other articles:


HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.